维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Nning L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Breast cancer prognostication and prediction;are we making progress显示文摘	L φnning PE		0，，8：	1
2	Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome:a longterm follow-up显示文摘	Mnning G Kbe J Lher A	2005	Heart Rhythm2005，2，：	1
3	Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase Ⅱ trial显示文摘	Lφnning PE Bajetta E Murray R	2000	J Clin Oncol2000，18，11：	1
4	Genomics in breast cancer-therapeutic implications显示文摘	L φnning PE S φrlie T B φrresen-Dale AL		0，，01：	1
5	Tensile strength of soil cores in relation to aggregate strength, soil fragmentation and pore characteristics显示文摘	Munkholm L J Schj ф nning P Kay B D	2002	Soil and Tillage Research2002，64，12：	1
6	Role of molecular markers in breast cancer therapy显示文摘Translational research,in general,means to take knowledge from one area into a second.Traditional thought to represent transfer of knowledge from basic research into the clinic,translational research today covers a much broader term.Thus,most investigators will agree translational research covers a two-way process that also includes taking lessons from the clinic back to the laboratory,by which biological observations in vivo would create novel hypotheses to be further explored in laboratory experiments.	Per Eystein LФnning	2010	中华乳腺病杂志(电子版)2010，4，5：	1
7	Exploring breast cancer estrogen disposition:the basis for endocrine manipulation显示文摘	L φnning PE Haynes BP Straume AH		0，，15：	1
8	Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status显示文摘	L φnning PE Helle H Duong NK		0，，1：	1
9	Additive endocrine therapy for advanced breast cancer-back to the future显示文摘	L φnning PE		0，，08：	1
10	High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy显示文摘	L φnning PE Taylor PD Anker G		0，，02：	1
11	P53 and its molecular basis to chemoresistance in breast cancer显示文摘	Knappskog S L nning PE	2012	Expert Opin Ther Targets2012，16，1：	1
12	Stepwise estrogen suppression manipulating the estrostat显示文摘	L φnning PE		0，，1：	1
13	Comparative electron microscopic studies of teleostean eggs with special reference to the chorion显示文摘	L?nning S	1972	Sarsia1972，49，：	1
14	Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status显示文摘	L?nning PE Helle H Duong NK	2009	J Steroid Biochem Mol Biol2009，117，13：	1
15	The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum显示文摘	Lnning PE	2011	Ann Oncol2011，22，3：	1
16	N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease显示文摘	KRAGELUND C GRNNING B KBER L		0，，07：	1
17	Endocrine effects of aromatase inhibitors and inactivators in vivo:review of data and method limitations 显示文摘	GEISLER J LФNNING P E	2005	J Steroid Biochem Mole Bioi2005，95，：	1
18	Surgical complications after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma: a consecutive series of 506 procedures显示文摘	Helene Halvorsen Jon Ramm-Pettersen Roger Josefsen P?l R?nning Sissel Reinlie Torstein Meling Jon Berg-Johnsen Jens Bollerslev Eirik Helseth	2014	Acta Neurochirurgica2014，，3：	1
19	Poor-prognosis estrogen receptor- positive disease:present and future clinical solutions显示文摘	L?nning PE	2012	Ther Adv Med Oncol2012，4，3：	1
20	High-dose estrogen treatment in postmenopausal breast Cancer patients heavily exposed to endocrine therapy显示文摘	L?nning PE Taylor PD Anker G		0，，02：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示